FDA Approves Broad Spectrum Parasite Protection for Cats
Drug Topics
APRIL 26, 2023
The NexGard COMBO topical solution from Boehringer Ingelheim helps protect cats from tapeworms and other intestinal parasites like fleas, ticks, and heartworms.
Wed.Apr 26, 2023
468 
World IP Day 2023: Celebrating women leaders in innovation
PhRMA
APRIL 26, 2023
Today PhRMA joins with innovators around the globe to recognize World IP Day and celebrate biopharmaceutical innovators who dedicate their lives to bringing new treatments and cures to patients. It’s also a day to reflect on the role Intellectual Property (IP) protections, such as patents, play in supporting the development of cutting-edge technologies.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Electrical Nerve Field Stimulation May Help IBS Symptoms in Pediatric Patients
Drug Topics
APRIL 26, 2023
IBS in pediatric patients has not been studied much, but new data reveals a possible treatment.
Scientists could finally be closing in on a ‘pill’ for men
PharmaVoice
APRIL 26, 2023
Drug developers have tried — and failed — to create a male contraceptive for decades. Now, one group of scientists might be on the verge of success.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Wait for RSV Vaccines Continues
Drug Topics
APRIL 26, 2023
Two RSV vaccines for seniors have completed phase 3 trials and demonstrated beneficial results. The public still awaits FDA decisions on potential approvals for both.
New AI-driven long COVID app coming soon to individual, enterprise customers
Fierce Healthcare
APRIL 26, 2023
New AI-driven long COVID app coming soon to individual, enterprise customers agliadkovskaya Wed, 04/26/2023 - 14:04
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Kaiser Permanente to acquire Geisinger Health in bid to launch multi-system VBC platform
Fierce Healthcare
APRIL 26, 2023
Kaiser Permanente to acquire Geisinger Health in bid to launch multi-system VBC platform dmuoio Wed, 04/26/2023 - 12:49
Eli Lilly's weight-loss drug passes 2nd trial with flying colors, setting up likely approval
Fierce Pharma
APRIL 26, 2023
Eli Lilly's weight-loss drug passes 2nd trial with flying colors, setting up likely approval aliu Wed, 04/26/2023 - 22:30
What gun violence costs U.S. healthcare: $1B in initial ER costs, hefty medical bills for patients
Fierce Healthcare
APRIL 26, 2023
What gun violence costs U.S.
Despite Lack of Consensus on Definition and Regulations, Digital Therapeutics Are Becoming General Medical Practice
Pharmacy Times
APRIL 26, 2023
The market for digital therapeutics products is expected to grow given increasing global access to smart technologies, their cost-effectiveness, and the need for patient-specific treatments.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Woman of the Week: Trevi Therapeutics’ Jennifer Good
PharmaVoice
APRIL 26, 2023
From startup to potential standout in the chronic cough space, Good is creating a new way of treating the unmet needs of patients.
OIG audit reveals lack of data sharing led to $128M in duplicate payments by Medicare, VA
Fierce Healthcare
APRIL 26, 2023
OIG audit reveals lack of data sharing led to $128M in duplicate payments by Medicare, VA aburky Wed, 04/26/2023 - 13:01
Pharmacists Report High Levels of Burnout, Resulting in Understaffing and Alternative Career Paths
Pharmacy Times
APRIL 26, 2023
Pharmacists were asked about their levels of burnout, drivers and symptoms of this burnout, and what steps their workplaces had taken to improve the issue.
Led by students, a nascent climate movement is taking hold in medical education
STAT
APRIL 26, 2023
When Cecilia Sorensen was an emergency medicine resident practicing at Denver Health in Colorado a few years ago, summer was known as “trauma season.” Gunshot and motor vehicle accident victims, people with heart attacks and COPD would stream into the ER. Later, on a fellowship, she witnessed the health impacts of drought in Syria. The common driver, she realized, was climate change and its impact, both locally and globally.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
As Biosimilars Change the Payer Landscape, Pharmacists Can Help Patients Access, Manage Complexities
Pharmacy Times
APRIL 26, 2023
Cate Lockhart, PharmD, PhD, executive director of the Biologics and Biosimilars Collective Intelligence Consortium, discussed the growing biosimilars landscape.
CMS announces tighter price transparency enforcement as Congress grills Chiquita Brooks-LaSure on weak compliance
Fierce Healthcare
APRIL 26, 2023
CMS announces tighter price transparency enforcement as Congress grills Chiquita Brooks-LaSure on weak compliance dmuoio Wed, 04/26/2023 - 18:19
Adjuvant Atezolizumab Combination May Reduce Risk of Fatal Recurrence of Liver Cancer Caused by Chronic Liver Disease
Pharmacy Times
APRIL 26, 2023
Up to 80% of patients with hepatocellular carcinoma will experience disease recurrence.
Breathing easy: How digital inhalers are changing asthma treatment
Pharmaceutical Technology
APRIL 26, 2023
AstraZeneca , Teva Pharmaceuticals , and Novartis , and other companies, are expanding their reach in the asthma space by capitalizing on digital technologies to enhance the patient experience. But experts say the complete integration of these devices and platforms into the healthcare system remains to be seen. Dr. Amy Chan, senior clinical research fellow at the School of Pharmacy, University of Auckland, says digital inhalers have existed for almost 30 years.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Despite Gaps in Use, Study Finds Individuals With Psychosocial, Structural Barriers More Likely to Use PrEP
Pharmacy Times
APRIL 26, 2023
Both barriers and facilitating factors, as well as a history of STIs, are associated with recent PrEP use among urban transgender women.
FDA approves first oral microbiome therapy Vowst. Will Nestlé be around to help Seres with the launch?
Fierce Pharma
APRIL 26, 2023
FDA approves first oral microbiome therapy Vowst. Will Nestlé be around to help Seres with the launch?
Study: Diet May Impact Sleep Pattern, But Not Duration
Pharmacy Times
APRIL 26, 2023
A higher carbohydrate diet was linked to earlier sleep and wake times, despite low carbohydrate consumption among study participants.
After shutting down, Akorn recalls its 70-plus products nationwide
Fierce Pharma
APRIL 26, 2023
After shutting down, Akorn recalls its 70-plus products nationwide zbecker Wed, 04/26/2023 - 16:06
Early-life Meningitis Associated with Risk of Developing Epilepsy in Later Childhood
Pharmacy Times
APRIL 26, 2023
Infants diagnosed with invasive Group B Streptococcus meningitis had an increased risk of developing epilepsy if the mother was of lower income.
Humana posts stronger-than-expected Q1 earnings with robust membership growth
Fierce Healthcare
APRIL 26, 2023
Humana posts stronger-than-expected Q1 earnings with robust membership growth hlandi Wed, 04/26/2023 - 07:30
Static Stretching Before Exercise Can Support Blood Vessel Health
Pharmacy Times
APRIL 26, 2023
This type of stretching allows for faster tissue oxygenation after the workout and protects from exercise stress.
After IRA, lawmakers look for more ways to cut drug prices
Fierce Pharma
APRIL 26, 2023
After IRA, lawmakers look for more ways to cut drug prices kdunleavy Wed, 04/26/2023 - 13:38
Payers reduce admin costs by going back to basics with payment integrity
Fierce Healthcare
APRIL 26, 2023
Payers reduce admin costs by going back to basics with payment integrity jpiatt Wed, 04/26/2023 - 16:09
Singapore startup Albatroz wins financing to develop solid tumour drugs
Pharmaceutical Technology
APRIL 26, 2023
Albatroz Therapeutics announced a successful $3 million financing round on April 26. This investment will be used to further the development of the Singapore-based pharmaceutical company’s solid tumour-focused monoclonal antibodies. The funding and a prize-win from Amgen will support the company’s drug development plans as Singapore continues developing its pharmaceutical market.
600,000 adults at risk of losing coverage under Republicans' Medicaid work requirement proposal, CBO estimates
Fierce Healthcare
APRIL 26, 2023
600,000 adults at risk of losing coverage under Republicans' Medicaid work requirement proposal, CBO estimates dmuoio Wed, 04/26/2023 - 16:10
The Compliance Team launches accreditation program for local health departments
Drug Store News
APRIL 26, 2023
TCT's new accreditation program is designed to build and strengthen staff competencies, among other initiatives.
What is clonidine used for in dogs?
The Checkup by Singlecare
APRIL 26, 2023
Many blood pressure medications are used off-label to help with anxiety. While beta blockers are well-known for the sense of calm they create, clonidine is another hypertension medication that may assist people when they’re trying to fall asleep or before a big speech. Specifically, it is a centrally acting alpha-2 agonist that works on certain receptors in the central nervous system to reduce the flow of noradrenaline which relaxes blood vessels, lowers blood pressure, and reduces heart rate or
Walgreens study: Seniors are less socially active now than before pandemic
Drug Store News
APRIL 26, 2023
An estimated 17 million (42%) of seniors agreed they are less socially active now than they were before the pandemic, while an estimated 8.2 million (20%) of seniors feel lonelier now than before the pandemic.
Novartis releases data for potentially “practice-changing” PNH medicine
European Pharmaceutical Review
APRIL 26, 2023
Oral iptacopan enabled an estimated 92.2 percent of complement-inhibitor-naïve, paroxysmal nocturnal haemoglobinuria (PNH) patients achieve 2 g/dL or more haemoglobin-level increase from baseline without the need for blood transfusions. The results show “oral iptacopan controls haemolysis while nearly eliminating the need for blood transfusions” These data from the Phase III APPOINT-PNH trial were presented at the 2023 Annual Meeting of the European Society for Blood and Marrow Transplantation (
Let's personalize your content